These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6788704)

  • 1. Specific Pseudomonas immunoglobulin E antibodies in sera of patients with cystic fibrosis.
    Shen J; Brackett R; Fischer T; Holder A; Kellogg F; Michael JG
    Infect Immun; 1981 May; 32(2):967-8. PubMed ID: 6788704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ELISA to detect antipseudomonal IgA antibodies in sera of patients with cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM
    J Clin Pathol; 1988 Oct; 41(10):1130-4. PubMed ID: 3142934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa flagellar antibodies in patients with cystic fibrosis.
    Anderson TR; Montie TC; Murphy MD; McCarthy VP
    J Clin Microbiol; 1989 Dec; 27(12):2789-93. PubMed ID: 2512326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum antibodies to Pseudomonas aeruginosa in cystic fibrosis.
    Brett MM; Ghoneim AT; Littlewood JM
    Arch Dis Child; 1986 Nov; 61(11):1114-20. PubMed ID: 3098186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. A survey.
    Hoiby N
    Acta Pathol Microbiol Scand Suppl; 1977; (262):1-96. PubMed ID: 411327
    [No Abstract]   [Full Text] [Related]  

  • 6. Analysis of naturally occurring antibodies to mucoid Pseudomonas aeruginosa in cystic fibrosis patients.
    Pier GB
    J Infect Dis; 1996 Feb; 173(2):513-5. PubMed ID: 8568328
    [No Abstract]   [Full Text] [Related]  

  • 7. Reaction of antibody in sera from cystic fibrosis patients with non-toxic forms of Pseudomonas aeruginosa exotoxin A.
    Klinger KW; Shuster CW; Klinger J
    Eur J Clin Microbiol; 1985 Apr; 4(2):201-6. PubMed ID: 3924609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of serum antibodies to Pseudomonas aeruginosa exoproteins in cystic fibrosis.
    Hollsing AE; Granström M; Vasil ML; Wretlind B; Strandvik B
    J Clin Microbiol; 1987 Oct; 25(10):1868-74. PubMed ID: 3117842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pseudomonas aeruginosa infection in cystic fibrosis. Relative prevalence of antibodies in serum against cathodic and anodic migrating P. aeruginosa antigens determined by immunoelectrophoretic methods.
    Holby N
    Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):149-52. PubMed ID: 67746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudomonas aeruginosa infection and humoral antibody response of patients with cystic fibrosis.
    Neter E
    J Infect Dis; 1974 Nov; 130 Suppl(0):S132-3. PubMed ID: 4213765
    [No Abstract]   [Full Text] [Related]  

  • 11. Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis.
    Shryock TR; Mollé JS; Klinger JD; Thomassen MJ
    J Clin Microbiol; 1986 Mar; 23(3):513-6. PubMed ID: 3082922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pseudomonas aeruginosa allergy in cystic fibrosis. Involvement of histamine release in the pathogenesis of lung tissue damage.
    Skov PS; Norn S; Schiøtz PO; Permin H; Høiby N
    Allergy; 1980 Jan; 35(1):23-9. PubMed ID: 6154430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis and pseudomonas infection.
    Lancet; 1983 Jul; 2(8344):257-8. PubMed ID: 6135081
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pseudomonas aeruginosa antibodies in patients with cystic fibrosis: clinical implications].
    Marianelli L; Campana S; Taccetti G; Gabbrielli M; Dei R
    Pediatr Med Chir; 1994; 16(6):551-4. PubMed ID: 7708538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study of IgG antibodies to Pseudomonas aeruginosa in early cystic fibrosis infection.
    Giordano A; Magni A; Filadoro F; Graziani C; Quattrucci S; Cipriani P
    New Microbiol; 1998 Oct; 21(4):375-8. PubMed ID: 9812319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonopsonic antibodies in cystic fibrosis. Pseudomonas aeruginosa lipopolysaccharide-specific immunoglobulin G antibodies from infected patient sera inhibit neutrophil oxidative responses.
    Eichler I; Joris L; Hsu YP; Van Wye J; Bram R; Moss R
    J Clin Invest; 1989 Dec; 84(6):1794-804. PubMed ID: 2512330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-Pseudomonas aeruginosa IgG subclass titers in patients with cystic fibrosis: correlations with pulmonary function, neutrophil chemotaxis, and phagocytosis.
    Cowan RG; Winnie GB
    J Clin Immunol; 1993 Sep; 13(5):359-70. PubMed ID: 8245182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa infection in cystic fibrosis. Occurrence of precipitating antibodies against pseudomonas aeruginosa in relation to the concentration of sixteen serum proteins and the clinical and radiographical status of the lungs.
    Hoiby N; Jacobsen L; Jorgensen BA; Lykkegaard E; Weeke B
    Acta Paediatr Scand; 1974 Nov; 63(6):843-8. PubMed ID: 4215280
    [No Abstract]   [Full Text] [Related]  

  • 19. Pseudomonas aeruginosa infection in cystic fibrosis. Bactericidal effect of serum from normal individuals and patients with cystic fibrosis on P. aeruginosa strains from patients with cystic fibrosis or other diseases.
    Holby N; Olling S
    Acta Pathol Microbiol Scand C; 1977 Apr; 85(2):107-14. PubMed ID: 404841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased levels of IgG subclasses specific for Pseudomonas aeruginosa exoenzyme and polysaccharide antigens in chronically infected patients with cystic fibrosis.
    Albus A; Saalmann M; Tesch H; Pedersen SS; Döring G
    APMIS; 1989 Dec; 97(12):1146-8. PubMed ID: 2482060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.